Voriconazole (Pinapu) 50/200mg | Beijing Genetech Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Pinapu (China Generic)

Pinapu is a Chinese generic of voriconazole produced by Beijing Genetech Pharmaceutical Co., Ltd., an NMPA-approved manufacturer. The listing offers film-coated tablets in two strengths — 50 mg and 200 mg, each box of ten — mirroring the originator's dosage options at a fraction of the brand price, which matters for patients paying out of pocket for an extended antifungal course.

What Is Voriconazole (Pinapu) Used For?

The medicine serves the same serious indications as branded voriconazole: invasive aspergillosis, candida bloodstream infection in non-neutropenic patients, oesophageal candidiasis, and difficult Fusarium or Scedosporium infections. In Chinese clinical practice, generic voriconazole is widely used in haematology and transplant wards, and it is also prescribed on discharge to complete a course begun in hospital.

How Does Voriconazole Work?

Pinapu contains the identical active molecule that blocks fungal ergosterol synthesis. By inhibiting 14-alpha-demethylase inside the fungal cell, it prevents construction of the membrane lipid fungi depend on for survival, stopping growth and, against susceptible moulds, killing the organism outright. The mechanism is broad enough to cover both Candida yeasts and Aspergillus moulds.

Indications

Approved indications cover invasive aspergillosis, candidemia and deep-tissue candidiasis in non-neutropenic patients, oesophageal candidiasis, and refractory Fusarium or Scedosporium apiospermum disease. A clinician selects the drug after identifying the fungus and, because generic and brand voriconazole share the same metabolism, therapeutic drug monitoring guides safe dosing exactly as it does for the originator.

Dosage

Adults start with a 6 mg/kg loading dose every 12 hours for 24 hours, then maintain on 200 mg twice daily by mouth; the 50 mg tablet allows finer weight-based or paediatric adjustments. Patients under 40 kg take 100 to 150 mg twice daily. The twice-daily oral route makes home continuation practical, and dosing is reduced by half in mild-to-moderate hepatic impairment.

Side Effects

The most distinctive effect is transient visual disturbance — blurring, photophobia or colour changes — usually reversible. Rash, nausea, headache and elevated liver enzymes are also common, while hepatic injury, QT prolongation and photosensitivity reactions are the serious events that demand monitoring. Patients should limit sun exposure and report any new visual symptom to the prescribing team.

Storage

Pinapu tablets are stable at room temperature in sealed packaging, requiring no refrigeration. Ambient-condition shipping preserves quality, and GLT dispatches from a Hong Kong-licensed facility with batch documentation and certificate of analysis included in every shipment.

Why Choose Pinapu Through GLT?

For self-funded patients the difference between brand and generic voriconazole can run into hundreds of dollars over a multi-week course. Pinapu delivers the same molecule with NMPA-approved manufacturing quality, and GLT's Hong Kong base makes this Chinese generic accessible to overseas buyers with transparent sourcing and batch traceability.

How to Order

To order Pinapu (voriconazole) from GLT, message us on WhatsApp at +86 15234153837 or email [email protected]. We confirm current stock, pack availability and delivery cost to your country, and ship from a Hong Kong-licensed facility.

FAQ

Is Pinapu the same as Vfend? Pinapu is a Chinese generic containing the same voriconazole molecule as the Pfizer originator Vfend, in matching 50 mg and 200 mg strengths.

Why two strengths? 200 mg is the standard adult dose, while 50 mg supports weight-based and paediatric adjustments.

Does a generic work the same? Yes — Chinese generics are approved after demonstrating bioequivalence to the originator.

Related Oncology Products

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

Eltrombopag (Promacta) 25mg/50mg Tablets | US Originator TPO-R Agonist | GLT

Novartis originator Promacta (eltrombopag) 25mg & 50mg, 30 tablets

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...